Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study.

EClinicalMedicine · 2022 · PMC9233170 · PMID 35770253

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Subgroup analysis by types of thromboembolic event (Appendix 9) did not result in any significant IRR except 14 to 27 days after second dose of CoronaVac for CVA [adjusted IRR: 1.36 (95% CI: 1.01-1.83)], which was marginally significant.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.